ÌÇÐÄvlog

[Skip to Navigation]
Sign In

November 2024 - July 1883

Decade

Year

Issue

February 21, 2023, Vol 329, No. 7, Pages 525-602

This Week in JAMA

Audio Highlights

Abstract Full Text
free access online only has audio
JAMA. 2023;329(7):e2215800. doi:10.1001/jama.2022.15800
Original Investigation

Aspirin Discontinuation at 24 to 28 Weeks’ Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA. 2023;329(7):542-550. doi:10.1001/jama.2023.0691

This randomized clinical trial aims to determine whether aspirin discontinuation in pregnant individuals with normal soluble fms-like tyrosine kinase–1 to placental growth factor (sFlt-1:PlGF) ratio between 24 and 28 weeks of gestation was noninferior to aspirin continuation to prevent preterm preeclampsia.

Association of African Ancestry–Specific APOE Missense Variant R145C With Risk of Alzheimer Disease

Abstract Full Text
free access
JAMA. 2023;329(7):551-560. doi:10.1001/jama.2023.0268

This exploratory case-control study assesses the association of APOE missense variants with risk of Alzheimer disease among individuals of African ancestry with the APOE ε3/ε4 genotype.

History of Low Hourly Wage and All-Cause Mortality Among Middle-aged Workers

Abstract Full Text
free access
JAMA. 2023;329(7):561-573. doi:10.1001/jama.2023.0367

This longitudinal study involving US workers collected wage information during a portion of peak earning years and examined whether a history of low-wage earning was associated with mortality risk.

Research Letter

Dissemination of the Results of Pediatric Clinical Trials Funded by the US National Institutes of Health

Abstract Full Text
free access
JAMA. 2023;329(7):590-592. doi:10.1001/jama.2022.24025

This study examines practices related to trial registration and results submission in ClinicalTrials.gov and publication of pediatric clinical trials funded by the National Institutes of Health.

Viewpoint

Assessing—and Extending—California’s Insulin Manufacturing Initiative

Abstract Full Text
JAMA. 2023;329(7):533-534. doi:10.1001/jama.2023.0013

This Viewpoint reviews California’s recently proposed CalRx initiative to manufacture biosimilar insulin, highlights challenges facing the initiative, and suggests ways in which, if successful, the initiative could serve as a model for state-managed development of drugs other than insulin, reduce drug prices, and provide other benefits.

The Importance of Shifting Sepsis Quality Measures From Processes to Outcomes

Abstract Full Text
JAMA. 2023;329(7):535-536. doi:10.1001/jama.2023.0340

This Viewpoint discusses the failure of the Centers for Medicare & Medicaid Services’ SEP-1 sepsis outcome improvement initiative to improve patients’ sepsis outcomes and suggests changing the focus of sepsis quality metrics from processes to outcomes.

A Piece of My Mind

Sanctity

Abstract Full Text
JAMA. 2023;329(7):537-538. doi:10.1001/jama.2022.24989

In this narrative medicine essay, an obstetrician finds relief from the frenetic intrusions of text messages, pages, and emails when in the operating room, where all devices are turned off and all her attention is turned on to her patient.

Editorial

Biomarkers and the Risk of Preeclampsia

Abstract Full Text
JAMA. 2023;329(7):539-541. doi:10.1001/jama.2022.24906
Review

Glioblastoma and Other Primary Brain Malignancies in Adults: A Review

Abstract Full Text
has active quiz has audio
JAMA. 2023;329(7):574-587. doi:10.1001/jama.2023.0023

This review summarizes current evidence regarding diagnosis and treatment of primary malignant brain tumors in adults.

JAMA Insights

Women's Health

Risk Factors, Symptoms, and Treatment of Lactational Mastitis

Abstract Full Text
has active quiz
JAMA. 2023;329(7):588-589. doi:10.1001/jama.2023.0004

This JAMA Insights Clinical Update reviews the risk factors for and symptoms of lactational mastitis and provides a potential treatment algorithm.

Medical News & Perspectives

New HIV Vaccine Approach Safely Stimulated Rare Precursors to Broadly Neutralizing Antibodies

Abstract Full Text
JAMA. 2023;329(7):527-528. doi:10.1001/jama.2022.23242

This Medical News article discusses a clinical trial for an HIV vaccine that uses germline targeting, a novel technique to induce rare immune cell precursors of broadly neutralizing antibodies.

Study Finds US Households, Especially in Rural Areas, Increasingly Shop at Dollar Stores for Food

Abstract Full Text
JAMA. 2023;329(7):529-530. doi:10.1001/jama.2023.0642

This Medical News article discusses a new study of household food purchasing trends from 2008 to 2020.

Medical News in Brief

National Academies: Expand US Wastewater Disease Surveillance

Abstract Full Text
JAMA. 2023;329(7):531. doi:10.1001/jama.2023.0739

High COVID-19 Rates Prompt Call for Better Nursing Home Protections

Abstract Full Text
free access
JAMA. 2023;329(7):531. doi:10.1001/jama.2023.0740

Agent Slows Glioblastoma Tumors in Mice by Blocking Fat Metabolism

Abstract Full Text
JAMA. 2023;329(7):531. doi:10.1001/jama.2023.0741

Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone

Abstract Full Text
JAMA. 2023;329(7):531. doi:10.1001/jama.2023.0743

New Report on Mpox Cases Leading Up to 2022 Global Outbreak

Abstract Full Text
JAMA. 2023;329(7):531. doi:10.1001/jama.2023.0744

Nearly 500 000 in UK May Have Missed Blood Pressure Drugs

Abstract Full Text
JAMA. 2023;329(7):531-532. doi:10.1001/jama.2023.0745

Both High- and Low-Dose Exercise Therapy Help Knee Osteoarthritis

Abstract Full Text
JAMA. 2023;329(7):532. doi:10.1001/jama.2023.0746

Vasopressors or High-Volume IV Fluids Both Effective for Sepsis

Abstract Full Text
JAMA. 2023;329(7):532. doi:10.1001/jama.2023.0747

Newly Discovered Host-Cell Factor Could Be a COVID-19 Treatment Target

Abstract Full Text
free access
JAMA. 2023;329(7):532. doi:10.1001/jama.2023.0748
Poetry and Medicine

The Hole

Abstract Full Text
JAMA. 2023;329(7):597. doi:10.1001/jama.2023.0212
JAMA Revisited

Seasonal Variability of Disease

Abstract Full Text
JAMA. 2023;329(7):598. doi:10.1001/jama.2022.15801
JAMA Patient Page

What Is Guillain-Barré Syndrome?

Abstract Full Text
free access
JAMA. 2023;329(7):602. doi:10.1001/jama.2022.24232

This JAMA Patient Page describes the autoimmune disease Guillain-Barré syndrome and its risk factors, diagnosis, treatment, and prognosis.

Comment & Response

Review of Pulmonary Embolism

Abstract Full Text
JAMA. 2023;329(7):592. doi:10.1001/jama.2022.22235

Review of Pulmonary Embolism

Abstract Full Text
JAMA. 2023;329(7):592-593. doi:10.1001/jama.2022.22232

Review of Pulmonary Embolism

Abstract Full Text
JAMA. 2023;329(7):593. doi:10.1001/jama.2022.22238

Review of Pulmonary Embolism—Reply

Abstract Full Text
JAMA. 2023;329(7):593-594. doi:10.1001/jama.2022.22241

Roflumilast Cream vs Vehicle Cream and Chronic Plaque Psoriasis

Abstract Full Text
JAMA. 2023;329(7):594-595. doi:10.1001/jama.2022.22646

Roflumilast Cream vs Vehicle Cream and Chronic Plaque Psoriasis—Reply

Abstract Full Text
JAMA. 2023;329(7):595. doi:10.1001/jama.2022.22649

Notice of Retraction and Replacement. Ellison-Barnes et al. Trends in Obesity Prevalence Among Adults Aged 18 Through 25 Years, 1976-2018. JAMA. 2021;326(20):2073-2074

Abstract Full Text
free access
JAMA. 2023;329(7):595-596. doi:10.1001/jama.2022.23438
JAMA Masthead

JAMA

Abstract Full Text
free access
JAMA. 2023;329(7):525-526. doi:10.1001/jama.2022.15799
×